Table 2.
Symptom scales |
|
|
||||
---|---|---|---|---|---|---|
Painful sites |
Intervention group (Arm A) |
Control group (Arm B) |
||||
n | Mean | SD | n | Mean | SD | |
Baseline (t0) |
30 |
39.78 |
23.91 |
30 |
39.56 |
24.51 |
3 month (t2) |
25 |
29.6 |
19.73 |
22 |
35.76 |
27.1 |
6 month (t3) |
18 |
22.22 |
13.14 |
18 |
35.93 |
32.67 |
Treatment effect (t0-t2) after 3 month p = 0.399, (t0-t3) after 6 month p = 0.445 | ||||||
Effect size (t0-t2) after 3 month -0.24, (t0-t3) after 6 month -0.43 | ||||||
Pain characteristics |
Intervention group (Arm A) |
Control group (Arm B) |
||||
|
n |
Mean |
SD |
n |
Mean |
SD |
Baseline (t0) |
30 |
48.15 |
31.47 |
30 |
54.81 |
33.13 |
3 month (t2) |
25 |
25.78 |
17.78 |
22 |
41.92 |
35.62 |
6 month (t3) |
18 |
25.31 |
19.73 |
18 |
45.06 |
36.65 |
Treatment effect (t0-t2) after 3 month p = 0.905, (t0-t3) after 6 month p = 0.761 | ||||||
Effect size (t0-t2) after 3 month -0.09, (t0-t3) after 6 month -0.24 | ||||||
Functional interference |
Intervention group (Arm A) |
Control group (Arm B) |
||||
|
n |
Mean |
SD |
n |
Mean |
SD |
Baseline (t0) |
30 |
55.14 |
26.32 |
30 |
55.28 |
28.95 |
3 month (t2) |
25 |
35.33 |
20.35 |
22 |
44.7 |
30.38 |
6 month (t3) |
18 |
29.86 |
20.77 |
18 |
48.38 |
30.12 |
Treatment effect (t0-t2) after 3 month p = 0.285, (t0-t3) after 6 month p = 0.081 | ||||||
Effect size (t0-t2) after 3 month -0.21, (t0-t3) after 6 month -0.56 | ||||||
Psychosocial aspects |
Intervention group (Arm A) |
Control group (Arm B) |
||||
|
n |
Mean |
SD |
n |
Mean |
SD |
Baseline (t0) |
30 |
69.26 |
17.0 |
30 |
57.59 |
19.87 |
3 month (t2) |
25 |
45.56 |
19.71 |
23 |
54.55 |
20.9 |
6 month (t3) |
18 |
41.05 |
19.1 |
18 |
50.93 |
20.55 |
Treatment effect (t0-t2) after 3 month p = 0.001, (t0-t3) after 6 month p = 0.010 | ||||||
Effect size (t0-t2) after 3 month -0.79, (t0-t3) after 6 month -0.77 |
Treatment effect and Cohen’s effect size after 3 and 6 month.